Africa: South Africa Delays Rollout of New Blockbuster HIV Drug

[Daily Maverick] Stocks of the new treatment are already on the shelves of some clinics -- but lingering concerns over a possible low risk of birth defects associated with this new antiretroviral have stalled the country's switch to better medication for a second time.